Retraction Note: BMC Cancer 18, 1286 (2018)
https://doi.org/10.1186/s12885-018-5199-3
The Editor in Chief retracted this article because of significant concerns regarding a number of Figures presented in this work, which question the integrity of the data. Specifically, a number of images appear to be the same and rotated between Fig. 2C, 2D and 4D in this article, and Fig. 2 and 3 in an article published earlier by unrelated authors ([1], now retracted). In addition, it appears that one image was re-used between Fig. 2D and 4D within this article.
The Editor-in-Chief therefore no longer has confidence in the integrity of the data in this article.
The authors have not responded to any correspondence from the editor or publisher about this retraction.
References
Huang, S, Jin, A. ZIC2 promotes viability and invasion of human osteosarcoma cells by suppressing SHIP2 expression and activating PI3K/AKT pathways. J Cell Biochem. 2018;119:2248–57. https://doi.org/10.1002/jcb.26387.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Tian, P., Zhu, Y., Zhang, C. et al. Retraction Note: Ras-ERK1/2 signaling contributes to the development of colorectal cancer via regulating H3K9ac. BMC Cancer 21, 594 (2021). https://doi.org/10.1186/s12885-021-08340-3
Published:
DOI: https://doi.org/10.1186/s12885-021-08340-3